Every GSP record · page 6
Every GSP record the index holds, newest first. Sort any column. The rollups are on the scorecard; this is the underlying evidence. GenScript Biotech Corporation sells direct at genscriptpeptides.com →.
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2024-004559 | Semaglutide | GSP-2405-W2517 | Kestrel | 2024-Q2 | 99.74 | 3.41 | — | Buyer-sourced | 1 | FAIL |
| AX-2024-004566 | Semaglutide | GSP-2405-W2517 | Kestrel | 2024-Q2 | 98.80 | 2.96 | — | Buyer-sourced | 1 | FAIL |
| AX-2024-004546 | TB-500 | GSP-2401-W1769 | Janoshik | 2024-Q2 | 98.73 | 7.32 | 90.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004558 | Semaglutide | GSP-2405-W2517 | Janoshik | 2024-Q2 | 99.22 | 2.96 | 106.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004549 | TB-500 | GSP-2401-W1769 | PeptideMeter | 2024-Q2 | 98.85 | 7.04 | 92.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004543 | TB-500 | GSP-2401-W1769 | Janoshik | 2024-Q2 | 99.21 | 7.18 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004565 | Semaglutide | GSP-2405-W2517 | Janoshik | 2024-Q2 | 98.69 | 3.33 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004572 | BPC-157 | GSP-2402-G2914 | Janoshik | 2024-Q1 | 99.03 | 4.27 | 96.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004570 | Hexarelin | GSP-2311-C2103 | VendorInvestigate | 2024-Q1 | 99.10 | 4.13 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004571 | BPC-157 | GSP-2402-G2914 | Medutest | 2024-Q1 | 99.01 | 3.96 | — | Laboratory-retained | 1 | FAIL |